Whistleblowing Under the False Claims Act

Similar documents
Anti-Kickback Statute and False Claims Act Enforcement

Corporate Compliance Program. Intended Audience: All SEH Associates 2016 Content Expert: Lisa Frey -

Improving Integrity in Nursing Centers

Clinical and Administrative Policies and Procedures

DEFICIT REDUCTION ACT AND FALSE CLAIMS POLICY INFORMATION FOR All NEW YORK WORKFORCE MEMBERS

The False Claims Act and Financial Institutions: A New Role for an Old Statute

False Claims Liability, Anti-Retaliation Protections, and Detecting and Responding to Fraud, Waste, and Abuse

WHISTLEBLOWERS. Agenda

WHISTLEBLOWERS. Agenda. Qui Tam Timeline. Sarbanes-Oxley. Qui Tam Timeline. Star Wars. Civil War WWII

The False Claims Act. False Claims Act Basics (I)

NewYork-Presbyterian Hospital Sites: All Centers Hospital Policy and Procedure Manual Number: D160 Page 1 of 8

Policy to Provide Information for Combating Fraud, Waste and Abuse and the Ability of Employees to Report Wrongdoing

U.S. v. Sulzbach: Government Theories, Potential Defenses, and Lessons Learned

Charging, Coding and Billing Compliance

DEFICIT REDUCTION ACT AND FALSE CLAIMS POLICY INFORMATION FOR All MASSACHUSETTS WORKFORCE MEMBERS

False Claims Act and Mandatory Disclosure Requirements for Federal Contractors

False Claims Act and Mandatory Disclosure Requirements for Federal Contractors

FRAUD, WASTE, & ABUSE (FWA) for Brokers. revised 10/17

C. Enrollees: A Medicaid beneficiary who is currently enrolled in the MCCMH PIHP.

Effective Date: 5/31/2007 Reissue Date: 10/08/2018. I. Summary of Policy

PATRICK S. COFFEY. Chicago, IL office: office:

Advisory. Connecticut False Claims Act: A New Arrow in the Quiver of State Regulators

Fraud and Abuse Compliance for the Health IT Industry

This policy applies to all employees, including management, contractors, and agents. For purpose of this policy, a contractor or agent is defined as:

DEPARTMENT OF HEALTH AND HUMAN SERVICES. Office of Inspector General s Use of Agreements to Protect the Integrity of Federal Health Care Programs

SOUTH NASSAU COMMUNITIES HOSPITAL One Healthy Way, Oceanside, NY 11572

HEATHER I. BATES Managing Director, BRG Health Analytics. BERKELEY RESEARCH GROUP, LLC 1800 M Street NW, 2 nd Floor Washington, DC 20036

State False Claims Acts

Corporate Compliance Topic: False Claims Act and Whistleblower Provisions

AGENCY POLICY. IDENTIFICATION NUMBER: CCD001 DATE APPROVED: Nov 1, 2017 POLICY NAME: False Claims & Whistleblower SUPERSEDES: May 18, 2009

FCA Settlement Raises Questions For Health IT

MATTHEW T. SCHELP. St. Louis, MO office:

Region 10 PIHP FY Corporate Compliance Program Plan

SUNY DOWNSTATE MEDICAL CENTER POLICY AND PROCEDURE. No:

FEDERAL DEFICIT REDUCTION ACT POLICY

False Claims Prevention

Coding Partners in Patient Safety

MFA COMPLIANCE 2016: UNDERSTANDING INSURANCE AND LIABILITY: A FOCUS ON D&O, CYBERSECURITY AND POLICY REVIEWS

Office of Inspector General. Regional Enforcement Efforts and Priorities in Florida. South Atlantic Regional Conference January 28, 2011

Federal and State False Claims Act Education Policy

This course is designed to provide Part B providers with an overview of the Medicare Fraud and Abuse program including:

Cardinal McCloskey Community Services. Corporate Compliance. False Claims Act and Whistleblower Provisions

CORPORATE COMPLIANCE POLICY AND PROCEDURE

Anti-Fraud Policy. The following non-exhaustive list provides a few examples of fraud that this Policy is designed to prevent and detect:

POLICY & PROCEDURE. Policy Title: False Claims Prevention Effective Date: 3/20/2013. Department: Compliance Policy Number: N/A

Conflicts of Interest 9/10/2017. Everything a Health Care Executive Needs to Know about the Anti-Kickback Statute. May 2, 2017 Article from JAMA:

Current Status: Active PolicyStat ID: Fraud, Waste and Abuse

Industry Funding of Continuing Medical Education

Physician Lease Arrangements: New Rules

Defending Whistleblower Cases: An Advanced View From the Trenches. Gregory M. Luce Jones Day

ANTI-FRAUD PLAN INTRODUCTION

Federal Deficit Reduction Act of 2005, Section 6032 on Fraud, Waste, and Abuse

The Road Ahead. Diane Meyer Chief Compliance and Privacy Officer Stanford University Medical Center

Coverage Issues Relating To Claims Under The False Claims Act

Mission Statement. Compliance & Fraud, Waste and Abuse Training for Network Providers 1/31/2019

Section (Primary Department) Medicaid Special Investigations Unit. Effective Date Date of Last Review 01/30/2015 Department Approval/Signature :

D E B R A S C H U C H E R T, C O M P L I A N C E O F F I C E R

1/29/2011. Mark G. Bodner Bureau Chief Complex Civil Enforcement Bureau Medicaid Control Unit Office of the Attorney General

Fraud, Waste and Abuse: Compliance Program. Section 4: National Provider Network Handbook

False Claims Act Enforcement in the Managed Care Space: Recent Trends and Proactive Compliance Tips

The Anesthesia Company Model: Frequently Asked Questions

AHLA. A. False Claims Act Primer. Thomas A. Corcoran Assistant US Attorney US Attorney s Office District of Maryland Baltimore, MD

FALSE CLAIMS ACT ENFORCEMENT: RECENT TRENDS AND STEPS TO ENSURE COMPLIANCE AND AVOID FRAUD ALLEGATIONS

Fraudulent Billing, CMS. Goals and Objectives. A deliberate deception For unfair or unlawful gain. Pharm 543 Don Downing. Goals

Effective Date: 1/01/07 N/A

Defending Corporations and Individuals in Government Investigations Ethics & Whistleblower Issues In Investigations

It s Here: The Final 60 Day Overpayment Rule

More Relators Push FCA Cases To The End In 2017

Committee Secretary Parliamentary Joint Committee on Corporation and Financial Services PO Box 6100 Parliament House Canberra ACT 2600

Health Care Compliance Association

Disclosures to the Government:

RESEARCH ENFORCEMENT Grant Fraud, Research Billing Irregularities and Other Scary Research Enforcement Issues

FWA (Fraud, Waste and Abuse) Training

Repay Overpayments (18 USC 1347; 42 CFR et seq.)

GERALD (JERRY) LEWANDOWSKI. BERKELEY RESEARCH GROUP, LLC 1800 M Street NW, Second Floor Washington, DC 20036

Self-Disclosure: Why, When, Where and How

This webinar is sponsored by the Fraud and Abuse Practice Group.

Potential Perils of Using New Media in Marketing and Promotion. Christina M. Markus (202)

Telemedicine Fraud and Abuse Under the Microscope

Stark Self-Disclosure. Thomas S. Crane 1/ Mintz Levin Cohn Ferris Glovsky and Popeo, PC

FAST BREAK : HOLIDAY GIFTS Jake Harper December 18, Morgan, Lewis & Bockius LLP

CORPORATE COMPLIANCE POLICY AND PROCEDURE

What Contractors Need to Know About Changes to State False Claims Acts September 11, 2012

LABORATORY CORPORATION OF AMERICA HOLDINGS BUSINESS PRACTICES MANUAL

REGULATORY ISSUES IMPACTING SUPPLY CHAIN

Conducting Internal Investigations: Staying Ethical in a Cost-Effective World November 7, 2014

This Webcast Will Begin Shortly

Bogies: Federal Anti- Kickback Law & EMS Contracting - Emerging Issues Pamela L. Johnston Foley & Lardner LLP Partner, Los Angeles.

11/10/2014. Nuts and Bolts of Proceedings related to Fraud, Recent Cases Update, and HIPAA Nuances. Objectives

The False Claims Act and Off-Label Promotion: Understanding and Minimizing the Risks for Pharmaceutical Manufacturers

In this course, we will cover the following topics: The structure and purpose of Navicent Health s Compliance Program The requirements of the

a publication of the health care compliance association SEPTEMBER 2018

STATEMENT OF MICHAEL F. HERTZ DEPUTY ASSISTANT ATTORNEY GENERAL CIVIL DIVISION UNITED STATES DEPARTMENT OF JUSTICE BEFORE THE

Anti-Kickback Statute Jess Smith

From the Office Suite to Cell Block C: Potential Criminal and Regulatory Implications of Pharma/Biotech/Device Products Liability Lawsuits

What s On Tap? Who Are the Players? 4/3/2017. Healthcare Enforcement Trends What To Do When the Government Comes Knocking?

HELAINE GREGORY, ESQ.

HOSPITAL COMPLIANCE POTENTIAL IMPLICATION OF FRAUD AND ABUSE LAWS AND REGULATIONS FOR HOSPITALS

Agenda. Strategic Considerations in Resolving Voluntary Government Disclosures

2/24/2017. Agenda. Determine Potential Liability. Strategic Considerations in Resolving Voluntary Government Disclosures. Relevant legal authorities:

Transcription:

Whistleblowing Under the False Claims Act Session 303, March 9, 2018 Colette G. Matzzie, Partner, Phillips & Cohen LLP Brendan Delaney, Implementation Specialist, Whistleblower 1

Conflict of Interest Colette G. Matzzie, JD Has no real or apparent conflicts of interest to report. 2

Conflict of Interest Brendan Delaney Has no real or apparent conflicts of interest to report. 3

Agenda Background on the False Claims Act. How a whistleblower lawyer evaluates a potential case. Considerations for whistleblowers before bringing a qui tam suit. Potential Violations of the FCA for Health IT Industry 4

Learning Objectives Explain the federal False Claim Act whistleblowing provisions and how they apply to the health IT industry Identify what practices the US federal government may see as violations of the False Claims Act and other considerations for would-be whistleblowers Discuss what information-and-technology-vendor employees, customer employees, and contractors can do if they see a potential problem Discuss experience of being a whistleblower and working with the Government in law enforcement 5

History of the False Claims Act The Health IT Industry s Newest Compliance Tool 6

Background on the False Claims Act Known as Lincoln s Law. Originally enacted during the Civil War to combat fraud by companies that sold supplies to the Union Army. Key provisions of the law were strengthened in 1986, 2009, and 2010, vastly increasing the law s reach from Lincoln s day. Qui Tam is from the Latin phrase, Qui tam pro domino rege quam pro se ipso in hac parte sequitur. Who pursues this action on our Lord the King s behalf as well as his own. 7

SUCCESS OF THE FCA $56 billion in federal civil recoveries as of 2017. Since 1987, the federal False Claims Act has returned over $56 billion in civil recoveries to the federal government. Over $9 billion in criminal fines as of 2016. Federal FCA lawsuits have also resulted in over $7 billion in associated criminal fines. Over $10 billion has gone back to the states as of 2016. Federal FCA lawsuits have also returned over $6 billion to state Medicaid programs. Sources: https://www.justice.gov/opa/pr/justice-department-recovers-over-37-billion-falseclaims-act-cases-fiscal-year-2017; https://taf.org/images/fcabrief16.pdf 8

SUCCESS OF THE FCA False Claims Act Recoveries by Industry, 2009-2017 Healthcare fraud: $22.08 billion Defense contractor fraud: More than $1.7 billion Housing and mortgage fraud: More than $7.5 billion Non-healthcare or defense fraud: $10.6 billion 9

SUCCESS OF THE FCA Top Healthcare Recoveries of 2017 Healthcare providers Life Care Centers of America ($145 million) Pharmaceutical/medical device Mylan ($465 million) Shire Pharmaceuticals ($350 million) Health IT eclinicalworks ($155 million) 10

How a Qui Tam Lawyer Evaluates a Potential Case What makes a False Claims Act violation? 11

Elements of an FCA Violation A False Claims Act violation must: Be false or fraudulent. Present a false claim to the government. Be material. Be done knowingly. 12

Elements of an FCA Violation False or Fraudulent. Providing products that do not conform to requirements. Misrepresentations to induce a contract or grant award. Not limited to express false statements. Includes misrepresentation by omission. What is a claim under the False Claims Act? Any request for money or property to be spent or used on the Government s behalf or to advance government interest, and funds provided or reimbursed by the Government. 13

Elements of a FCA Violation Cause to be presented An entity or individual who causes another to present a false claim to the Government, or agents of the Government, is liable. An EHR vendor could be liable for false claims presented to CMS by a health care practitioner using the vendor s software, even if the EHR vendor didn t directly make that specific false claim. 14

Cause to be Presented Example 15

Elements of a FCA Violation Materiality. The claim has a natural tendency to cause payment. The false claims must be a significant violation of the contract or law. Consider: Will Government agencies (ONC/CMS/OIG/DOJ) support these allegations as material? Knowingly. Mistakes and mere negligence not enough. Government knowledge not a defense but can be relevant. 16

Whistleblower s Considerations Do I have a strong case? Are patients at risk because of what I am alleging? Will I be willing to assist the Government investigation? Can I handle the stress of a long investigation under seal? What are the litigation risks? Can I strengthen my case by joining with another relator (whistleblower)? Am I prepared for retaliation and the possible risks to my career? 17

Additional Considerations by a Lawyer What information does the relator (whistleblower) have? What is the relator s background? Has the fraud been publicly disclosed? What evidence exists to prove the fraud? Has a similar case been filed? Does the Government know about the allegations? What are the damages? Can the defendant pay? 18

Whistleblower Protection in the FCA Protects any employee, contractor or agent, Who is in any manner discriminated against in the terms and conditions of employment, Because of lawful acts in support of qui tam, or to stop FCA violation taken by the individual or associated others. Not limited to discrimination by the defendant. Relief: Double back-pay, interest on back-pay, reinstatement, special damages, litigation costs and reasonable attorneys fees. Statute of limitations: 3 years. 19

Mechanics of Filing a Qui Tam Case All False Claims Act cases are filed under seal. Under seal means nobody knows about the lawsuit except the gov t. Whistleblower s identity is not revealed publicly until court lifts the seal. Lawsuit is served on a US Attorney s Office and to DOJ. NOT directly served on the company or individual. Intervention decision. Will the government join the lawsuit? Possible litigation and role of relator. 20

Whistleblower Assistance with a Government Investigation Government interviews the whistleblower. Witnesses are identified. Whistleblower produces relevant, non-privileged documents. Civil administrative subpoenas or civil investigative demands. Deposition of current employees. Assistance with criminal investigation. 21

Enforcement Remedies False Claims Act lawsuits can result in civil or criminal charges, which can result in: Damages and civil penalties. Criminal fines and restitution. Role of the Office of Inspector General Civil monetary penalties Corporate Integrity Agreements 22

Whistleblower Awards FCA Whistleblowers are entitled to financial rewards if their case is successful. Given for substantial contribution to the case. Relators can be awarded between 15% and 30% of the total recovery. Attorneys fees, costs and expenses for the relator are paid by the defendant when there is a settlement. This figure is often in addition to (i.e. not included in) the announced settlement agreement on DOJ s website. 23

Potential Violations of the FCA Implications for Health IT 24

Potential Qui Tam Cases in Health IT Fraudulent meaningful use certification False statements and fraudulent conduct. Software not MU compliant and/or patient safety risks. MU stage 2 & 3. Failure to perform required functionality RxNorm, SNOMED CT, CVX, and LOINC codes. CPOE issues. CQM issues. 25

Potential Qui Tam Cases in Health IT Violations of the Anti-Kickback Statute Improper payments to purchasers. Payments to/from providers including pharmaceutical companies, pharmacies, medical device vendors, home health or rehab or other providers, even billing services. 26

Potential Qui Tam Cases in Health IT Upcoding/overbilling Clinical decision support/use of order sets. Provider schemes for overutilization/misuse of system. 27

There are troubling indications that some providers are using this technology to game the system, possibly to obtain payments to which they are not entitled There are also reports that some hospitals may be using electronic health records to facilitate upcoding of the intensity of care or severity of patients condition as a means to profit with no commensurate improvement in the quality of care. - 2012 letter to several hospital associations from then-hhs Secretary Kathleen Sebelius and Attorney General Eric Holder. 28

Potential Qui Tam Cases in Health IT WHAT COMES NEXT? 29

Potential Qui Tam Cases in Health IT Population-based health tools Data integrity. Predictive analytics. Clinical decision support/risk stratification/case management. Quality-based payment and managed care payment systems MIPS, ACOs, star ratings. 30

Questions Colette G. Matzzie cmatzzie@phillipsandcohen.com 202-833-4567 Brendan Delaney bpdelaney75@gmail.com @fraudmatters facebook.com/phillipsandcohen www.phillipsandcohen.com Please complete the online session evaluation! 31